BioCorRx (BICX) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.00% |
| Dec 31, 2025 | 15.49% |
| Sep 30, 2025 | 18.46% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 37.59% |
| Dec 31, 2024 | 15.92% |
| Sep 30, 2024 | 63.18% |
| Jun 30, 2024 | -15.09% |
| Mar 31, 2024 | 16.41% |
| Dec 31, 2023 | -35.99% |
| Sep 30, 2023 | 34.20% |
| Jun 30, 2023 | -14.99% |
| Mar 31, 2023 | 74.47% |
| Dec 31, 2022 | 15.05% |
| Sep 30, 2022 | 38.87% |
| Jun 30, 2022 | 34.40% |
| Mar 31, 2022 | -39.65% |
| Dec 31, 2021 | -66.17% |
| Sep 30, 2021 | 15.31% |
| Jun 30, 2021 | -25.76% |
| Mar 31, 2021 | 72.77% |
| Dec 31, 2020 | -29.40% |
| Sep 30, 2020 | -34.67% |
| Jun 30, 2020 | -46.55% |
| Mar 31, 2020 | -84.31% |
| Dec 31, 2019 | -87.11% |
| Sep 30, 2019 | -31.33% |
| Jun 30, 2019 | 90.29% |
| Mar 31, 2019 | -71.61% |
| Dec 31, 2018 | -20.27% |
| Mar 31, 2018 | -15.75% |
| Dec 31, 2017 | -144.64% |
| Sep 30, 2017 | 16.53% |
| Jun 30, 2017 | -20.77% |
| Mar 31, 2017 | 328.44% |
| Dec 31, 2016 | 106.24% |
| Sep 30, 2016 | -160.83% |
| Jun 30, 2016 | 187.91% |
| Mar 31, 2016 | -96.16% |
| Dec 31, 2015 | 60.66% |
| Sep 30, 2015 | -26.68% |